Skip to main content
. 2011 Aug 10;6(8):e23354. doi: 10.1371/journal.pone.0023354

Figure 7. Withaferin A (WA) treatment causes activation of Bak and Bax in breast cancer cells.

Figure 7

Immunofluorescence microscopy for active Bak and Bax in MDA-MB-231 (A), MCF-7 (B), and HMEC (C) following 24 h treatment with DMSO (control) or 2.5 µM WA. Each experiment was repeated at least twice.